publish time

30/06/2024

author name Arab Times

publish time

30/06/2024

The trend of self-medicating with Ozempic and Mounjaro raises concerns among medical experts.

KUWAIT CITY, June 30: In recent years, the popularity of weight loss drugs such as "Ozempic" and "Mounjaro" has sparked what is now dubbed the "injection fashion" trend. These medications, readily available online and through medical pharmacies, have led some individuals to self-administer them without proper medical guidance, relying solely on package recommendations or online advice for desired results.

Dr. Muhammad Ibrahim, a consultant bariatric surgeon at Wara Hospital, cautions that while these injections generally have a good safety profile and rare health complications, they are potent medical treatments with potential side effects and risks if not managed under medical supervision.

"It's crucial for anyone considering these injections to consult a specialized doctor rather than risk self-administration. These medications are typically prescribed for individuals with overweight or mild obesity, but comprehensive health evaluations are essential beforehand," Dr. Ibrahim emphasized in an interview with Al-Qabas.

Before initiating treatment with injections like "Mounjaro" or "Ozempic," Dr. Ibrahim stresses the necessity of undergoing several medical tests, including comprehensive blood tests, liver function evaluations, and assessments for thyroid and vitamin deficiencies. Routine monitoring every six months is also advised to manage any emerging health issues and nutritional deficiencies.

Understanding "Ozempic" vs. "Mounjaro"

Dr. Ibrahim delineates the distinctions between "Ozempic" and "Mounjaro" injections:

  • Mounjaro injection: Contains GLP-1 and GIP hormones, impacting blood sugar levels and appetite suppression.
  • Ozempic injection: Contains GLP-1, primarily regulating insulin secretion and aiding in blood sugar control, with additional benefits for cardiovascular health.

Efficacy and costs

In terms of effectiveness, "Mongaro" injections are expected to induce a more pronounced weight loss of 20-25% compared to 15-20% with "Ozempic," albeit at a higher cost ranging from 150 to 300 dinars monthly for "Mongaro" versus 35 to 50 dinars for "Ozempic."

Potential side effects and contraindications

Both types of injections may cause nausea, fatigue, and gastrointestinal discomfort. Rare complications include pancreatitis, gallstones, severe allergic reactions, and depression, necessitating immediate medical attention.

Long-term commitment and comparisons with bariatric surgery

Dr. Ibrahim underscores the importance of long-term adherence to injection regimens for sustained weight management. While injections are suitable for modest weight loss goals, bariatric surgery remains a more effective and enduring option for severe obesity cases, yielding weight loss of 35-50% with minimal risks.

"Injections are recommended for overweight individuals, whereas surgical interventions offer faster and more substantial weight loss for severe obesity," Dr. Ibrahim clarified. He highlighted the safety and efficacy of modern bariatric procedures, making them viable even for individuals with chronic conditions or older adults.

As the debate between injections and surgery continues, Dr. Ibrahim advocates for informed decision-making guided by individual health needs and goals, ensuring sustainable weight management and overall well-being.